← SynDRA
IDARUBICIN
SynDRA canonical compound SYN0003829 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TOP2A |
| Mechanism of action | Topoisomerase inhibitor |
| Indication | acute myeloid leukemia (AML) |
| Disease area | hematologic malignancy |
All known targets
- TOP2A
- ABCB1
- ABCC1
- TOP2A; TOP2B
Mechanisms of action (all sources)
- topoisomerase inhibitor
- TOP2A INHIBITOR
- DNA topoisomerase II alpha inhibitor
- Modulator
Drug classes
- Topoisomerase Inhibitors
- Anthracycline Topoisomerase Inhibitor
- Antibiotics, Antineoplastic
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
ATC classes
- L01D · CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Cross-references
Synonyms
- 4-Demethoxydaunomycin
- 4-Demethoxydaunorubicin
- demethoxydaunorubicin
- idarubicin hydrochloride
- idarubicin HCl
- Idarubicine
- Idarubicina
- DMDR
- Idamycin
- Idarubicinum
- Zavedos
- Idarubicin Hcl
- Idarubicin Hcl Pfs
- Idarubicin hydrochloride
- DM5
- I 1656
- IMI-30
- Idamycin (TN)
- Idarubicin (INN)
- Idarubicin [INN:BAN]
- Idarubicina [INN-Spanish]
- Idarubicine [INN-French]
- Idarubicinum [INN-Latin]
- Zavedos (TN)
- (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
- (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside
- (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
- (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
- 4-DMD
- 4-Desmethoxydaunorubicin
- NSC 256439
- ZRP63D75JW
- CHEBI:42068
- 5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
- IDARUBICIN [INN]
- Idarubicinhydrochloride
- (7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
Look up IDARUBICIN in the interactive SynDRA portal →